News & Updates

In women receiving hormone therapy for breast cancer, both mat Pilates and belly dance can help improve cardiorespiratory fitness and body composition, as shown in a study.

Initiation of sodium–glucose cotransporter‐2 (SGLT2) inhibitor therapy upon hospital discharge is associated with improved clinical outcomes among patients with acute heart failure (HF), especially those with frailty, according to the West Tokyo Heart Failure 2 (WET‐HF 2) registry in Japan.

In postmenopausal women with or without breast cancer, once-weekly treatment with vaginal tamoxifen helps reduce anxiety symptoms and relieve pain, as shown in a study.

Higher intakes of total refined carbohydrate and rice appear to increase the risk of developing metabolic dysfunction-associated steatotic liver disease (MASLD), but consumption of wheat, coarse grains, and yams may mitigate such threat, suggests a study.

Using high-efficiency particulate air (HEPA) filters on top of existing infection-prevention measures in care homes does little to further reduce respiratory and other infections, as shown in a study.

In the phase II CELIA trial, the investigational tau-targeting antisense oligonucleotide (ASO) diranersen has shown therapeutic potential in patients with early Alzheimer’s disease (AD), yielding substantial reductions in tau burden and slowing clinical decline despite missing its primary endpoint.

Treatment with simvastatin appears to improve survival in some patients with cirrhosis after variceal bleed, suggests a study. The drug also reduces the incidence of new-onset, refractory ascites and its complications.

Oral administration of proton-pump inhibitor (PPI) helps reduce the risk of delayed bleeding in gastric endoscopic mucosal resection (G-EMR) and gastric endoscopic submucosal dissection (G-ESD) but not in esophageal endoscopic mucosal resection (E-EMR), esophageal endoscopic submucosal dissection (E-ESD), and percutaneous endoscopic gastrostomy (PEG), according to a study.

Intercycle delays in first-line systemic chemotherapy do not appear to negatively affect survival among patients with metastatic or recurrent cervical cancer, reveals a study.